Q4 2024 Management View CEO Tim Herbert highlighted milestones in 2024, including surpassing 90,000 patients treated with Inspire therapy, FDA approval of the Inspire V neurostimulator, and achieving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback